Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and II.


OBJECTIVE:To evaluate the efficacy of ubrogepant on patient-reported functional disability, satisfaction with study medication, and global impression of change. BACKGROUND:Ubrogepant is a small-molecule, oral calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine. In 2 phase 3 trials (ACHIEVE I and II), ubrogepant demonstrated efficacy vs placebo on the 2 co-primary endpoints of headache pain freedom and absence of the most bothersome migraine-associated symptom at 2 hours post dose for the 50 and 100 mg doses. Patient-reported outcomes, such as functional disability, satisfaction, and patient global impression of change, can provide additional evidence of the efficacy of an acute treatment for migraine on clinically meaningful and patient-relevant outcomes. METHODS:ACHIEVE I and ACHIEVE II were multicenter, randomized, double-blind, placebo-controlled, parallel-group, single-attack trials in adults (18-75 years) with migraine. In ACHIEVE I, participants were randomized 1:1:1 to placebo or ubrogepant 50 or 100 mg; in ACHIEVE II, participants were randomized 1:1:1 to placebo or ubrogepant 25 or 50 mg to treat a migraine attack with moderate or severe headache pain. Participants rated ability to perform daily activities on the Functional Disability Scale, before dosing and at 1, 2, 4, and 8 hours after the initial dose; satisfaction with study medication at 2 and 24 hours; and impression of overall change in migraine on the Patient Global Impression of Change scale at 2 hours. In prespecified analyses for each trial, each outcome was compared between each ubrogepant dose group and the relevant placebo group. Data were pooled from the ubrogepant 50 mg and placebo groups of the 2 trials in a post hoc analysis. RESULTS:In ACHIEVE I, 559 participants were randomized to placebo, 556 to ubrogepant 50 mg, and 557 to ubrogepant 100 mg; in ACHIEVE II, 563 were randomized to placebo, 561 to ubrogepant 25 mg, and 562 to ubrogepant 50 mg. At 2 hours post dose, significantly higher proportions of ubrogepant-treated participants vs placebo-treated participants reported being able to function normally (ACHIEVE I: ubrogepant 50 mg, 40.6% [171/421], P = .0012 vs placebo; ubrogepant 100 mg, 42.9% [192/448], P < .0001 vs placebo; placebo, 29.8% [136/456]; ACHIEVE II: ubrogepant 25 mg, 42.6% [185/434], P = .0015 vs placebo; ubrogepant 50 mg, 40.5% [188/464], P = .0118 vs placebo; placebo, 34.2% [156/456]; pooled 50 mg, 40.6% [359/885], vs pooled placebo, 32.0% [292/912]; P < .0001), were satisfied/extremely satisfied with study medication (ACHIEVE I: 50 mg, 36.3% [147/405], P < .0001 vs placebo; 100 mg, 35.8% [149/416], P = .0002 vs placebo; placebo, 24.1% [104/432]; ACHIEVE II: 25 mg, 35.1% [141/402], P = .0018 vs placebo; 50 mg, 37.8% [163/431], P < .0001 vs placebo; placebo, 24.8% [106/427]; pooled ubrogepant 50 mg, 37.1% [310/836], vs pooled placebo, 24.5% [210/859]; P < .0001), and indicated that their migraine was much/very much better on the Patient Global Impression of Change scale (ACHIEVE I: 50 mg, 34.4% [103/299], P = .0006 vs placebo; 100 mg, 34.3% [102/297], P = .0009 vs placebo; placebo, 22.0% [69/313]; ACHIEVE II: 25 mg, 34.1% [124/364], P < .0001 vs placebo; 50 mg, 33.4% [131/392], P = .0002 vs placebo; placebo, 20.7% [78/376]; pooled 50 mg, 33.9% [234/691], vs pooled placebo, 21.3% [147/689]; P < .0001). CONCLUSIONS:A significantly higher proportion of participants treated with ubrogepant were able to function normally, were satisfied with the study medication, and reported clinically meaningful improvement compared with those receiving placebo. The results reinforce the potential benefits of ubrogepant on patient-centered outcomes in the acute treatment of migraine.






Dodick DW,Lipton RB,Ailani J,Halker Singh RB,Shewale AR,Zhao S,Trugman JM,Yu SY,Viswanathan HN




Has Abstract


2020-04-01 00:00:00














  • An update on the epidemiology of migraine.

    abstract::Epidemiologic studies provide estimates of the scope and distribution of the public health problems posed by migraine. These studies have been facilitated by the development of the International Headache Society criteria for migraine, which have now been used in separate prevalence studies in several countries. In thi...


    pub_type: 杂志文章,评审


    authors: Lipton RB,Silberstein SD,Stewart WF

    更新日期:1994-06-01 00:00:00

  • Episodic acute migraine treatment.

    abstract::The ideal migraine medication would provide rapid “one and done” treatment of migraine for all sufferers. Unfortunately, no such intervention is available. While most people respond to triptans or DHE, some will need to combine these with an NSAID, or will choose to use an NSAID alone because of personal preference or...


    pub_type: 杂志文章


    authors: Tepper D

    更新日期:2014-11-01 00:00:00

  • Gender, primary headache, and psychological distress.

    abstract::The study compared the psychological symptoms of 26 young men and 65 young women referred to a neurology clinic in northern Israel by their family physicians for medical advice regarding headache. The main findings indicated that the women had more severe psychological symptoms than the men in six subscales, although ...


    pub_type: 杂志文章


    authors: Gilbar O,Bazak Y,Harel Y

    更新日期:1998-01-01 00:00:00

  • Psychophysiological response patterns of migraine patients in two habituation tests.

    abstract:OBJECTIVE:To investigate the habituation response pattern of patients with migraine to a simple standard stressor and to a more complex performance-dependent (achievement) stressor in three peripheral systems (electrodermal, vasomotor, and cardiovascular). We hypothesized that the migraine patients would show abnormal ...


    pub_type: 临床试验,杂志文章


    authors: Huber D,Henrich G,Gündel H

    更新日期:2005-11-01 00:00:00

  • Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial.

    abstract:OBJECTIVE:To evaluate the long-term tolerability of telcagepant for acute treatment of intermittent migraine attacks. Background.- Telcagepant is a calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine. METHODS:Migraine patients were randomized 2:1 to double-...


    pub_type: 杂志文章,随机对照试验


    authors: Connor KM,Aurora SK,Loeys T,Ashina M,Jones C,Giezek H,Massaad R,Williams-Diaz A,Lines C,Ho TW

    更新日期:2011-01-01 00:00:00

  • A Brief Look at Urgent Care Visits for Migraine: The Care Received and Ideas to Guide Migraine Care in this Proliferating Medical Setting.

    abstract:OBJECTIVE:There has been a rise in urgent care centers throughout the country over the past 10 years, leading to an increase in patients accessing medical care in these locations. These centers advertise an alternative to the Emergency Department (ED) for the evaluation and treatment of urgent medical conditions. The g...


    pub_type: 杂志文章


    authors: Minen MT,Zhou K,Miller L

    更新日期:2020-03-01 00:00:00

  • Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.

    abstract:OBJECTIVE:To describe the pharmacokinetic and safety profiles of sumatriptan 85 mg formulated with RT Technology (RT) and naproxen sodium 500 mg in a fixed-dose combination tablet (sumatriptan/naproxen sodium) that targets both serotonergic dysmodulation and inflammation in migraine. METHODS:Six open-label, crossover ...


    pub_type: 临床试验,杂志文章


    authors: Haberer LJ,Walls CM,Lener SE,Taylor DR,McDonald SA

    更新日期:2010-03-01 00:00:00

  • Deficiency in serum ionized magnesium but not total magnesium in patients with migraines. Possible role of ICa2+/IMg2+ ratio.

    abstract::It has been suggested that magnesium (Mg) may play a role in the pathogenesis of headaches. Serum and intracellular measurements of Mg in headache patients have produced inconsistent results. The recent development of an ion-selective electrode for Mg2+ allowed precise measurement of serum ionized magnesium (IMg2+) in...


    pub_type: 杂志文章


    authors: Mauskop A,Altura BT,Cracco RQ,Altura BM

    更新日期:1993-03-01 00:00:00

  • Remote electrical neuromodulation for acute treatment of migraine in adolescents.

    abstract:OBJECTIVES:Migraine is a common disabling neurological disorder. Current acute treatments for migraine in adolescents are mostly pharmacological and may have limited effectiveness, can cause side effects, and may lead to medication overuse. There is an unmet need for effective and well-tolerated treatments. Remote elec...


    pub_type: 杂志文章


    authors: Hershey AD,Lin T,Gruper Y,Harris D,Ironi A,Berk T,Szperka CL,Berenson F

    更新日期:2020-12-21 00:00:00

  • Lifetime prevalence and correlates of migraine among women in a pacific northwest pregnancy cohort study.

    abstract:BACKGROUND:Migraine is a common neurological disorder, ranked among the world's leading causes of years lived with disability by the World Health Organization. The burden of migraine is highest in women of reproductive age. METHODS:We characterized the prevalence, symptoms, and correlates of migraine and other headach...


    pub_type: 杂志文章


    authors: Frederick IO,Qiu C,Enquobahrie DA,Aurora SK,Peterlin BL,Gelaye B,Williams MA

    更新日期:2014-04-01 00:00:00

  • Prevalence and impact of headache and migraine among secondary school students in Nigeria.

    abstract:BACKGROUND:A cross-sectional descriptive study to determine the overall, age and gender specific prevalence, trigger factors and impact of headache and migraine on quality of life of students attending secondary schools in Benin City, Nigeria. METHODS:Six secondary schools were randomly selected from which students we...


    pub_type: 杂志文章


    authors: Ofovwe GE,Ofili AN

    更新日期:2010-11-01 00:00:00

  • The development of a survey to measure completeness of response to migraine therapy.

    abstract:OBJECTIVE:To assess the psychometric properties of a new patient-reported migraine instrument, the Completeness of Response Survey (CORS), which measures a comprehensive set of factors important to patients' decisions regarding the initiation and continuation of treatment. BACKGROUND:Traditionally, migraine treatments...


    pub_type: 杂志文章,多中心研究


    authors: Coon CD,Fehnel SE,Davis KH,Runken MC,Beach ME,Cady RK

    更新日期:2012-04-01 00:00:00

  • Sensitivity to various stimuli in primary headaches: a questionnaire study.

    abstract::Questions about discomfort or pain produced by various stimuli (e.g., light, sound, exercise, neck movements) are currently used to differentiate between various primary headache disorders. In order to evaluate the usefulness of differences in sensitivity to physical stimuli in headache diagnosis, the answers to a que...


    pub_type: 杂志文章


    authors: Vingen JV,Sand T,Stovner LJ

    更新日期:1999-09-01 00:00:00

  • Understanding the patient with migraine: the evolution from episodic headache to chronic neurologic disease. A proposed classification of patients with headache.

    abstract::Traditionally, episodic primary headache disorders are characterized by a return of preheadache (normal) neurologic function between episodes of headache. In contrast, patients with chronic headache often do not return to normal neurologic function between headache attacks. This article proposes that the evolution fro...


    pub_type: 杂志文章


    authors: Cady RK,Schreiber CP,Farmer KU

    更新日期:2004-05-01 00:00:00

  • Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies.

    abstract:BACKGROUND:The pathophysiology of chronic migraine (CM) is not fully understood. We aimed to examine transcranial magnetic stimulation (TMS) indices of cortical excitability in patients with CM and also performed PET studies to ascertain if there were any areas of activation and inhibition for possible correlation. ME...


    pub_type: 杂志文章


    authors: Aurora SK,Barrodale PM,Tipton RL,Khodavirdi A

    更新日期:2007-07-01 00:00:00

  • SUNCT syndrome. Two cases in Argentina.

    abstract::Two patients suffering from SUNCT syndrome are presented. Some features are remarkable. The first patient was a 69-year-old man whose first crisis was located in the right supraorbital region. After a 4-month spontaneous remission, the pain returned to the upper part of the cheek, radiating to the supraciliary region ...


    pub_type: 杂志文章


    authors: Raimondi E,Gardella L

    更新日期:1998-05-01 00:00:00

  • Prevalence and impact of migraine among US Army soldiers deployed in support of Operation Iraqi Freedom.

    abstract:OBJECTIVES:To assess the prevalence and impact of migraine headaches in US Army soldiers deployed in support of Operation Iraqi Freedom. METHODS:A brigade of US Army soldiers stationed at Ft. Lewis, Washingtion was given a self-administered headache questionnaire within 10 days of return from a 1-year combat tour in I...


    pub_type: 杂志文章


    authors: Theeler BJ,Mercer R,Erickson JC

    更新日期:2008-06-01 00:00:00

  • Clinical, anatomical, and physiologic relationship between sleep and headache.

    abstract::The intimate relationship between sleep and headache has been recognized for centuries, yet the relationship remains clinically and nosologically complex. Headaches associated with nocturnal sleep have often been perceived as either the cause or result of disrupted sleep. An understanding of the anatomy and physiology...


    pub_type: 杂志文章


    authors: Dodick DW,Eross EJ,Parish JM,Silber M

    更新日期:2003-03-01 00:00:00

  • Cushing syndrome induced by serial occipital nerve blocks containing corticosteroids.

    abstract::A patient with chronic daily headaches developed overt signs of Cushing syndrome during treatment with serial occipital nerve block injections. Investigation demonstrated an exogenous source of corticosteroids as the cause of the Cushing syndrome in this patient, thus, implicating the corticosteroid component of the o...


    pub_type: 杂志文章


    authors: Lavin PJ,Workman R

    更新日期:2001-10-01 00:00:00

  • Intravenous magnesium sulfate relieves cluster headaches in patients with low serum ionized magnesium levels.

    abstract::Patients with cluster headaches have been reported to have low serum ionized magnesium levels. We examined the possibility that patients with cluster headaches and low ionized magnesium levels may respond to an intravenous infusion of magnesium sulfate. Thirty-eight infusions of magnesium sulfate were given to 22 pati...


    pub_type: 杂志文章


    authors: Mauskop A,Altura BT,Cracco RQ,Altura BM

    更新日期:1995-11-01 00:00:00

  • Coping style and social support in men and women suffering from cluster headache or migraine.

    abstract:OBJECTIVE:To investigate similarities and differences between patients with cluster headache and patients with migraine. BACKGROUND:Patients with migraine and patients with cluster headache are considered, by many clinical neurologists, to be different psychologically and socially. METHODS:Twenty-five age-matched pai...


    pub_type: 杂志文章


    authors: Blomkvist V,Hannerz J,Katz L,Theorell T

    更新日期:2002-03-01 00:00:00

  • Reimbursement-Based Economics--What Is It and How Can We Use It to Inform Drug Policy Reform?

    abstract:BACKGROUND:In Ontario, approximately $3.8 billion is spent annually on publicly funded drug programs. The annual growth in Ontario Public Drug Program (OPDP) expenditure has been limited to 1.2% over the course of 3 years. Concurrently, the Ontario Drug Policy Research Network (ODPRN) was appointed to conduct drug clas...


    pub_type: 杂志文章,评审


    authors: Coyle D,Lee KM,Mamdani M,Sabarre KA,Tingley K

    更新日期:2015-07-01 00:00:00

  • Flunarizine in migraine: a minireview.

    abstract::Flunarizine is a non-selective calcium antagonist. It distributes preferentially in the adipose tissue and passes the blood brain barrier. Numerous controlled clinical studies have established that flunarizine is efficacious in migraine prophylaxis, including double-blind studies in which the drug was compared with pl...


    pub_type: 临床试验,杂志文章,随机对照试验,评审


    authors: Leone M,Grazzi L,La Mantia L,Bussone G

    更新日期:1991-06-01 00:00:00

  • Ischemic colitis associated with naratriptan and oral contraceptive use.

    abstract::Ischemic colitis has not been reported in association with naratriptan therapy. We describe the occurrence of ischemic colitis in a patient who was treated with abortive doses of naratriptan for migraine and was also taking long-term oral contraceptives. Concurrent use of naratriptan and oral contraceptives should pro...


    pub_type: 杂志文章


    authors: Charles JA,Pullicino PM,Stoopack PM,Shroff Y

    更新日期:2005-04-01 00:00:00

  • Acute demyelination mimicking vascular hemicrania.

    abstract::A 29-year-old woman presented with acute hemicrania, trigeminal neuropathy and posterior fossa dysfunction. The admission differential diagnosis included vertebral artery dissection, posterior circulation aneurysm, vascular malformation and brainstem infarction. However, radiographic and CSF studies indicated demyelin...


    pub_type: 杂志文章


    authors: Nager BJ,Lanska DJ,Daroff RB

    更新日期:1989-07-01 00:00:00

  • Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.

    abstract:OBJECTIVE:To examine the disability, health care resource utilization, and direct annual costs among patients with migraine, categorized according to the number of headache days experienced in the past month. BACKGROUND:Migraine exists on a continuum of different attack frequencies and associated levels of disability....


    pub_type: 杂志文章


    authors: Silberstein SD,Lee L,Gandhi K,Fitzgerald T,Bell J,Cohen JM

    更新日期:2018-11-01 00:00:00

  • Spontaneous oscillations in cerebral blood flow velocity give evidence of different autonomic dysfunctions in various types of headache.

    abstract:OBJECTIVES:Our objectives were to determine if: (1) patients with migraine have B wave abnormalities in comparison to normal controls and patients with chronic tension headache and (2) patients with chronic tension headache have an imbalance in autonomic activity that is reflected in differences in Mayer wave activity ...


    pub_type: 杂志文章


    authors: Sliwka U,Harscher S,Diehl RR,van Schayck R,Niesen WD,Weiller C

    更新日期:2001-02-01 00:00:00

  • Central sensitization theory of migraine: clinical implications.

    abstract::The clinical science of migraine headache continues to evolve. Theories of the pathophysiology of migraine have progressed from the early vascular basis of migraine to more complex current theories that emphasize the centrality of neuronal dysfunction. The most recently articulated theory of migraine is the central se...


    pub_type: 杂志文章,评审


    authors: Dodick D,Silberstein S

    更新日期:2006-11-01 00:00:00

  • A history of cigarette smoking is associated with the development of cranial autonomic symptoms with migraine headaches.

    abstract:OBJECTIVE:To look at the smoking history of migraine patients and to determine if a history of cigarette smoking is associated with the development of cranial autonomic symptoms with migraine headaches. BACKGROUND:It has recently been noted that a significant number of migraine patients may develop autonomic symptoms ...


    pub_type: 杂志文章


    authors: Rozen TD

    更新日期:2011-01-01 00:00:00

  • Pain, emotion, headache.

    abstract::Pain has been considered as part of a defensive strategy whose specific role is to signal an immediate active danger to the organism. This definition fits well for acute pain. It does not work well, however, for chronic pain that is maintained even in absence of an ongoing, active threat. Currently, acute and chronic ...


    pub_type: 杂志文章,评审


    authors: Bussone G,Grazzi L,Panerai AE

    更新日期:2012-10-01 00:00:00